P-one clinic
Hachioji, Tokyo, Japan
Medical clinic in Hachioji
8-1-1004 Yokamachi, Hachioji, Tokyo 192-0071
About P-one clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
9
Eli Lilly and Company
8
Hoffmann-La Roche
2
Mochida Pharmaceutical Company, Ltd.
2
Astellas Pharma Global Development, Inc.
1
H. Lundbeck A/S
1
Swedish Orphan Biovitrum
1
Clinical Trials at P-one clinic
During the past decade, P-one clinic conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 2 clinical trials were completed, i.e. on
average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy
2015-01-01
2015-03-01
Completed
12
Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects
2016-08-01
2016-10-01
Completed
10
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults
2018-08-27
2018-11-15
Completed
15
A Study of LY3209590 in Japanese Participants With Type 2 Diabetes
2018-08-17
2019-05-27
Completed
31
A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects
2018-08-20
2018-10-02
Completed
8
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "P-one clinic" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 8 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Mochida Pharmaceutical Company, Ltd." with 2 trials sponsored and "Astellas Pharma Global Development, Inc."
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "P-one clinic"
#1 collaborator was "Fuji Yakuhin Co., Ltd." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at P-one clinic
According to Clinical.Site data, the most researched conditions in "P-one clinic" are
"Healthy" (10 trials), "Alzheimer Disease" (4 trials), "Diabetes Mellitus, Type 2" (4 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "P-one clinic" in a lesser frequency.
Clinical Trials Intervention Types at P-one clinic
Most popular intervention types in "P-one clinic" are "Drug" (23 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Donanemab" (2 trials), "FYU-981" (2 trials), "Gantenerumab" (2 trials) and "LY3209590" (2 trials). Other intervention names were less common.
Clinical Trials Genders at P-one clinic
The vast majority of trials in "P-one clinic" are
22 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at P-one clinic
Currently, there are NaN active trials in "P-one clinic".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in P-one clinic,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in P-one clinic, 19 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".